872 filings
Page 2 of 44
8-K
qmkx7powk0n 5omgc3
15 Feb 24
BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
5:15pm
424B1
0khieis u1s
14 Feb 24
Prospectus with pricing info
9:21pm
EFFECT
k4e0df61tnb mv
14 Feb 24
Notice of effectiveness
12:15am
CORRESP
1mn49e6dvxcuonx uio
9 Feb 24
Correspondence with SEC
12:00am
8-K
3g41o3
7 Feb 24
Results of Operations and Financial Condition
6:04am
8-K
8i1 nxdzh26a
29 Jan 24
Biolase Reports Unaudited Revenue Growth for Full Year 2023 and Provides
5:01pm
S-8
rfacxfdax6w 793g8hj
24 Jan 24
Registration of securities for employees
5:21pm
UPLOAD
2yb5zh1lbkn2m
24 Jan 24
Letter from SEC
12:00am
8-K
haf2v2li3ihgw3eh vd8
29 Dec 23
Departure of Directors or Certain Officers
4:05pm
D
r6qvbh2 b1ec
20 Dec 23
$2.73 mm in equity / options / securities to be acquired, sold $2.73 mm, 1 investor
2:13pm
8-K
kdwq wx4n
8 Dec 23
Biolase, Inc. Announces Pricing of $1.4 Million Registered Direct
9:25am
424B5
amoajbfsumi ea8
8 Dec 23
Prospectus supplement for primary offering
9:23am
8-K
naf49cyb0g4wy7wc9v
17 Nov 23
Entry into a Material Definitive Agreement
4:17pm
8-K
9k23 jhivkganbwgnn
9 Nov 23
Results of Operations and Financial Condition
4:20pm